Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapy
Chronic myeloid leukemia (CML) is a blood cancer characterized by dysregulated production of maturing myeloid cells driven by the product of the Philadelphia chromosome, the BCR-ABL1 tyrosine kinase. Tyrosine kinase inhibitors (TKIs) have proved effective in treating CML, but there is still a cohort...
Main Authors: | Jonathan Rodriguez, Abdon Iniguez, Nilamani Jena, Prasanthi Tata, Zhong-Ying Liu, Arthur D Lander, John Lowengrub, Richard A Van Etten |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2023-04-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/84149 |
Similar Items
-
Hedgehog Signaling in Myeloid Malignancies
by: Ajay Abraham, et al.
Published: (2021-09-01) -
Myelopoiesis during Solid Cancers and Strategies for Immunotherapy
by: Tyler J. Wildes, et al.
Published: (2021-04-01) -
Extramedullary hematopoiesis in the axillary lymph node in a patient with an accelerated phase of chronic myeloid leukemia
by: Gülşah Kaygusuz, et al.
Published: (2009-03-01) -
The dark side of stemness – the role of hematopoietic stem cells in development of blood malignancies
by: Jadwiga Filipek-Gorzała, et al.
Published: (2024-02-01) -
Molecular and epigenetic alterations in normal and malignant myelopoiesis in human leukemia 60 (HL60) promyelocytic cell line model
by: Jhinuk Basu, et al.
Published: (2023-02-01)